From symplicity htn-3 to the renal denervation global registry: Where do we stand and where should we go

EuroIntervention

Volumn 10, Issue 1, 2014, Pages 21-24

  Pathak, Atul ^a   Ewen, Sebastian ^b   Fajadet, Jean ^c   Honton, Benjamin ^c   Mahfoud, Felix ^b   Marco, Jean ^d   Schlaich, Markus ^e   Schmieder, Roland ^f   Tsioufis, Konstantinos ^g   Ukena, Christian ^b   Zeller, Thomas ^h  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b SAARLAND UNIVERSITY   (Germany)

^c CLINIQUE PASTEUR   (France)

^d EuroPCR   (France)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g UNIVERSITY OF ATHENS   (Greece)

^h UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; VASODILATOR AGENT;

AFRICAN AMERICAN; ARTERY DISSECTION; BLOOD PRESSURE MONITORING; DIABETES MELLITUS; HEART RATE; HUMAN; HYPERTENSION; KIDNEY DENERVATION; LEARNING CURVE; MEDICATION COMPLIANCE; PATIENT SELECTION; RENAL ARTERY; RENAL ARTERY DISSECTION; RESISTANT HYPERTENSION; REVIEW; SHAM PROCEDURE; SYMPATHETIC TONE; INNERVATION; KIDNEY; PROCEDURES; REGISTER; SURGERY; SYMPATHECTOMY; TREATMENT OUTCOME;

HUMANS; HYPERTENSION; KIDNEY; REGISTRIES; RENAL ARTERY; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84902357566     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I1A4     Document Type: Review

References (21)

1. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-401.
2. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57:1076-80.
3. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898-902.
4. Savard S, Frank M, Bobrie G, Plouin PF, Sapoval M, Azizi M. Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients. J Am Coll Cardiol. 2012;60:2422-4.
5. Tsioufis C, Papademetriou V, Worthley M, Chew D, Sinhal A, Meredith I, Malaiapan Y, Worthley S. Differential impact of renal sympathetic denervation on indexes of short-term blood pressure variability in patients with resistant hypertension. J Am Coll Cardiol. 2014;63(12-S):A1307.
6. Zuern CS, Eick C, Rizas KD, Bauer S, Langer H, Gawaz M, Bauer A. Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol. 2013;62:2124-30.
7. Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Rixe J, Hamm C, Nef H. Soluble fms-Like Tyrosine Kinase-1 and Endothelial Adhesion Molecules (Intercellular Cell Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1) as Predictive Markers for Blood Pressure Reduction After Renal Sympathetic Denervation. Hypertension. 2014;63:984-90.
8. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation. 2008;118:1383-93.
9. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-81.
10. Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich M, Schmieder R, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G. Effect of renal denervation in a real world population of patients with uncontrolled hypertension-The Global SYMPLICITY Registry. ACC Washington DC 2014; Late Breaking Clinical Trials.
11. Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, Toennes SW. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31:766-74.
12. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011;123:1940-6.
13. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011;29:991-6.
14. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-65.
15. Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, Ewen S, Schotten U, Maack C, Wirth K, Böhm M. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension. 2013;62:767-74.
16. Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, Laufs U, Mahfoud F, Böhm M. Improvements of left-ventricular hypertrophy and diastolic function following renal denervation-Effects beyond blood pressure and heart rate reduction. J Am Coll Cardiol. 2013 Nov 25. [Epub ahead of print].
17. Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M, Kelle S. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014 Mar 6. [Epub ahead of print].
18. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M. Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology. J Cardiovasc Electrophysiol. 2013;24:1028-33.
19. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-70.
20. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol. 2012;101:63-7.
21. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, Hamady M, Hughes AD, Sever PS, Sobotka PA, Francis DP. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162:189-92.